InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-5.3%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Lanning Mark R, Director. Director active across 1 company, notably AtriCure, Inc.. Cumulatively, 4 filings have been logged. History available since 5 May 2021. The latest transaction was filed on 5 May 2021 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations4 total
10,000 shares@ US$14.1750.0% of flowCommon StockSEC:0001209191-21-030782
10,000 shares@ US$14.170.0083% mcap50.0% of flowCommon StockSEC:0001209191-21-030782:0
20,000 sharesCommon StockSEC:0001209191-16-090772:0
30,000 sharesCommon StockSEC:0001209191-16-090772:1
4 of 4 declarations
About Lanning Mark R
Mark R. Lanning is a Director at AtriCure, Inc. In this role, he participates in the strategic direction of the company and important decision-making. His expertise in the medical sector is valuable to the board.
